Proenkephalin A 119–159 predicts early and successful liberation from renal replacement therapy in critically ill patients with acute kidney injury: a post hoc analysis of the ELAIN trial

Proenkephalin A 119–159 predicts early and successful liberation from renal replacement therapy in critically ill patients with acute kidney injury: a post hoc analysis of the ELAIN trial

Abstract Background Renal replacement therapy (RRT) remains the key rescue therapy for critically ill patients with severe acute kidney injury (AKI). However, there are currently no tools available to predict successful liberation from RRT. Biomarkers may allow for risk stratification and individual...

Full description

Bibliographic Details
Main Authors: Thilo von Groote, Felix Albert, Melanie Meersch, Raphael Koch, Christian Porschen, Oliver Hartmann, Deborah Bergmann, Peter Pickkers, Alexander Zarbock
Format: Article
Language:English
Published: BMC 2022-10-01
Series:Critical Care
Subjects:
Acute kidney injury
AKI
Biomarker
ELAIN
Renal replacement therapy
Proenkephalin A
Online Access:https://doi.org/10.1186/s13054-022-04217-4

Internet

https://doi.org/10.1186/s13054-022-04217-4

Similar Items